Michael J. Farrell
Chairman and CEO, Director, ResMed |
Bought, 12 months
$0.0M
Sold, 12 months
$14.6M
Companies
1
Latest trade
Oct 7, 2026
Companies
ResMed |Chairman and CEO, Director −$16.9MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.
